The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
Officials say there are still a number of people in the hospital. Their fear is that the death toll could rise.
What is the significance of topics such as the Ease of Doing Business (EoDB), deregulation, challenges posed by AI, and NIPUN Bharat Mission have on both the UPSC preliminary and main exams? You can ...